Lungs News and Research

RSS

Elevation presents positive data from EP-101 Phase 2a study on COPD at ERS annual meeting

Elevation Pharmaceuticals, Inc., a biopharmaceutical company focused on the development of new aerosol therapies for patients with respiratory diseases, announced today that it presented positive results from a Phase 2a study of EP-101 in patients with moderate to severe chronic obstructive pulmonary disease (COPD), a large and growing disease characterized by significant unmet clinical needs, at the annual meeting of the European Respiratory Society.

27 Sep 2011

Novartis files marketing authorisation with EMA for NVA237 to treat COPD

Sosei Group Corporation, today announces that NVA237 (glycopyrronium bromide), a long-acting muscarinic antagonist (LAMA) being investigated as a once-daily treatment for chronic obstructive pulmonary disease (COPD), has been filed by Novartis for marketing authorisation with the European Medicines Agency (EMA), under the brand-name Seebri Breezhaler, triggering a $5m milestone payment to Sosei.

27 Sep 2011

Data from YM BioSciences' nimotuzumab clinical trials to be reported at ECCO-ESMO 2011

YM BioSciences Inc., a drug development company advancing a diverse portfolio of hematology and cancer-related products, today announced that data from several clinical trials of nimotuzumab are scheduled be reported at the 2011 European Multidisciplinary Cancer Congress (ECCO-ESMO), September 23-27, 2011, in Stockholm, Sweden.

27 Sep 2011

Study: Underweight COPD patients more likely to face death

Patients suffering from chronic obstructive pulmonary disease (COPD) are at a higher risk of death if they are underweight.

27 Sep 2011

Synta announces results of ganetespib, docetaxel Phase 1 combination study on solid tumors

Synta Pharmaceuticals Corp. announced that results of a Phase 1 study of ganetespib in combination with docetaxel in solid tumors were presented at the Annual Meeting of the European Society of Medical Oncology in Stockholm, Sweden.

27 Sep 2011

People with COPD, reduced lung function more likely to develop cardiovascular disease

A new study has shown that people with chronic obstructive pulmonary disease (COPD) or people with reduced lung function are at a serious risk of developing cardiovascular disease.

26 Sep 2011

Asthma patients admitted to hospital with H1N1 are half as likely to die from infection

People with asthma who are admitted to hospital with pandemic influenza H1N1 (swine flu) are half as likely to die or require intensive care than those without asthma, according to new research.

26 Sep 2011

InterMune reports new data from Esbriet clinical trial on IPF

InterMune, Inc. today reported that new data was presented at the European Respiratory Society (ERS) Annual Congress supporting the longer-term safety and tolerability of Esbriet(pirfenidone) in patients with idiopathic pulmonary fibrosis (IPF), a devastating lung disease.

26 Sep 2011

Study identifies areas for cancer care cost and quality improvements

With cancer care costs rising at an unprecedented rate, The US Oncology Network, one of the nation's largest networks of community-based oncologists dedicated to advancing cancer care in America, reported a study that identified areas where both the cost and quality of care could be improved.

26 Sep 2011

City cyclists inhale more black carbon than pedestrians

People who cycle through London and other major cities have higher levels of black carbon in their airway cells, experts from the UK have shown.

26 Sep 2011

'Time matters' in the fight against pulmonary hypertension

The Pulmonary Hypertension Association Europe (PHA EU) has launched ‘Time Matters’ a new campaign which encourages people with Pulmonary Hypertension (PH) and their friends and family to share hopes and dreams for the future in order to raise awareness of this deadly and rapidly progressive condition. By logging on to the website http://phtimematters.org and posting an entry, everybody can help the patient association take a step towards increased awareness and understanding of this devastating condition.

26 Sep 2011

Moderate alcohol intake can reduce risk of asthma

Drinking alcohol in moderate quantities can reduce the risk of asthma, according to Danish researchers.

26 Sep 2011

Social and economic impact of COPD on working population

New research has revealed the devastating personal and financial impact that chronic obstructive pulmonary disease (COPD) can have on the working population.

26 Sep 2011

Exposure to goats could increase risk of pneumonic-type lung adenocarcinoma

Exposure to goats could increase the risk of a certain type of lung cancer, according to French researchers.

26 Sep 2011

Study highlights individual and combined effect of obesity on asthma development

Belly fat, known clinically as central obesity, has been linked to the development of asthma in a new study.

26 Sep 2011

Scientists identify genetic variants associated with lung health

Scientists have for the first time discovered sixteen new sections of the genetic code that relate to lung health -- opening up the possibility for better prevention as well as treatment for lung diseases.

26 Sep 2011

Diffusion-weighted MRI can accurately detect lung cancer

A new type of diagnostic imaging - which can better differentiate benign lung lesions from those which are cancerous - could be used to prevent unnecessary surgery by enabling more accurate diagnosis of the disease.

26 Sep 2011

Study finds link between increased respiratory symptoms and lower altitude areas of river valleys

The research will be presented tomorrow at the European Respiratory Society's (ERS) Annual Congress in Amsterdam. The ERS Congress will officially open today. In the first study of its kind, researchers from the UK aimed to assess the impact of weather, pollution and geography on the symptoms of people with chronic obstructive pulmonary disease.

26 Sep 2011

Study examines link between mother's occupation and asthma prevalence among children

Mothers who are exposed to particular agents during pregnancy could give birth to children with a higher risk of asthma, according to new research.

26 Sep 2011

YM BioSciences total revenue decreases to $1.5 million for fiscal 2011

YM BioSciences Inc., a drug development company advancing a diverse portfolio of promising hematology and cancer-related products, today reported operational and financial results for its 2011 fiscal year, ended June 30, 2011.

23 Sep 2011

Lungs News and Research

Elevation presents positive data from EP-101 Phase 2a study on COPD at ERS annual meeting

Novartis files marketing authorisation with EMA for NVA237 to treat COPD

Data from YM BioSciences' nimotuzumab clinical trials to be reported at ECCO-ESMO 2011

Study: Underweight COPD patients more likely to face death

Synta announces results of ganetespib, docetaxel Phase 1 combination study on solid tumors

People with COPD, reduced lung function more likely to develop cardiovascular disease

Asthma patients admitted to hospital with H1N1 are half as likely to die from infection

InterMune reports new data from Esbriet clinical trial on IPF

Study identifies areas for cancer care cost and quality improvements

City cyclists inhale more black carbon than pedestrians

'Time matters' in the fight against pulmonary hypertension

Moderate alcohol intake can reduce risk of asthma

Social and economic impact of COPD on working population

Exposure to goats could increase risk of pneumonic-type lung adenocarcinoma

Study highlights individual and combined effect of obesity on asthma development

Scientists identify genetic variants associated with lung health

Diffusion-weighted MRI can accurately detect lung cancer

Study finds link between increased respiratory symptoms and lower altitude areas of river valleys

Study examines link between mother's occupation and asthma prevalence among children

YM BioSciences total revenue decreases to $1.5 million for fiscal 2011

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News